Breaking Gene Therapy News
-
A New Goal for Gene Therapy: Pet Contraception
May 24, 2018 | 22:34 pmA New Goal for Gene Therapy: Pet Contraception PLoS Blogs (blog)Full coverage
Read more... -
ABO-102 Gene Therapy for Type A Patients Continues to Show Key and Durable Benefits in Trial, Abeona Reports
May 24, 2018 | 19:48 pmABO-102 Gene Therapy for Type A Patients Continues to Show Key and Durable Benefits in Trial, Abeona Reports Sanfilippo NewsFull coverage
Read more... -
VWR, Part of Avantor, Named Sole Supplier for Cell and Gene Therapy Catapult
May 24, 2018 | 15:09 pmVWR, Part of Avantor, Named Sole Supplier for Cell and Gene Therapy Catapult PR Newswire UK (press release)Full coverage
Read more... -
3 Things In Biotech, May 23: Gene Therapy Continues To Promise
May 24, 2018 | 14:00 pm3 Things In Biotech, May 23: Gene Therapy Continues To Promise Seeking AlphaFull coverage
Read more... -
Bluebird bags breakthrough status for CALD gene therapy
May 24, 2018 | 12:26 pmBluebird bags breakthrough status for CALD gene therapy PMLiVEbluebird's Lenti-D Gets Breakthrough Therapy Status From FDA NasdaqFDA 'Breakthrough' status for tafamidis and Lenti-D The Pharma LetterFull coverage
Read more... -
AveXis To Build New Gene Therapy Drug Manufacturing Facility In North Carolina
May 24, 2018 | 07:22 amAveXis To Build New Gene Therapy Drug Manufacturing Facility In North Carolina Pharmaceutical Online (press release)Full coverage
Read more... -
Vectalys, FlashCell Merge to Form Gene Therapy Company
May 23, 2018 | 23:17 pmVectalys, FlashCell Merge to Form Gene Therapy Company BioPharm InternationalFull coverage
Read more... -
Seeing Is Believing: A Gene Therapy First
May 23, 2018 | 19:18 pmSeeing Is Believing: A Gene Therapy First GlobeNewswire (press release)Full coverage
Read more... -
Novartis' brand-new gene therapy player AveXis will build $55M plant, hire 200
May 23, 2018 | 17:59 pmNovartis' brand-new gene therapy player AveXis will build $55M plant, hire 200 FiercePharmaNovartis-owned AveXis bringing $55M gene therapy factory, 200 jobs to Durham WRAL Tech WireGene therapy company to create 200 jobs in North Carolina WRAL.comFull coverage
Read more... -
CALD Gene Therapy Granted Breakthrough Therapy Designation
May 23, 2018 | 15:16 pmCALD Gene Therapy Granted Breakthrough Therapy Designation Rare Disease ReportFull coverage
Read more... -
CAR-T's Launch, Payers vs. Gene Therapy & Photos From “What's Hot”
May 23, 2018 | 13:00 pmCAR-T's Launch, Payers vs. Gene Therapy & Photos From “What's Hot” XconomyFull coverage
Read more... -
Adverum: Assessing The Strong Prospects Of A Gene Therapy Innovator
May 23, 2018 | 12:00 pmAdverum: Assessing The Strong Prospects Of A Gene Therapy Innovator Seeking AlphaFull coverage
Read more... -
BioMarin ups the ante for pivotal haemophilia gene therapy trial
May 23, 2018 | 11:57 amBioMarin ups the ante for pivotal haemophilia gene therapy trial PMLiVEFull coverage
Read more... -
Why Analysts Remain Bullish On This Hemophilia Gene-Therapy Play
May 22, 2018 | 23:22 pmWhy Analysts Remain Bullish On This Hemophilia Gene-Therapy Play Investor's Business DailyMomentum grows for hemophilia gene therapies BioPharma DiveFull coverage
Read more... -
FDA chief Gottlieb is building a regulatory speedway to accelerate gene therapy development
May 22, 2018 | 22:42 pmFDA chief Gottlieb is building a regulatory speedway to accelerate gene therapy development Endpoints NewsFDA plans to speed path to approval for some gene therapies, starting with hemophilia STATGene Therapies That Could Transform Diseases Get Easier FDA Path BloombergFull coverage
Read more... -
Gene therapy company bringing 200 jobs to Durham
May 22, 2018 | 18:22 pmGene therapy company bringing 200 jobs to Durham News & ObserverFull coverage
Read more... -
Buoyed by hemophilia A gene therapy update, BioMarin switches to head-to-head study — but shares slide on ...
May 22, 2018 | 17:38 pmBuoyed by hemophilia A gene therapy update, BioMarin switches to head-to-head study — but shares slide on ... Endpoints NewsBioMarin Provides 2 Years of Clinical Data in 6e13 vg/kg Dose from Ongoing Phase 1/2 Study in Valoctocogene ... PR Newswire (press release)Full coverage
Read more... -
Spark hemophilia B gene therapy clears test en route to Pfizer-sponsored phase 3
May 22, 2018 | 15:37 pmSpark hemophilia B gene therapy clears test en route to Pfizer-sponsored phase 3 FierceBiotechHunting a cure, Spark reports steady progress on hemophilia B gene therapy as Pfizer preps for pivotal handoff Endpoints NewsSpark's gene therapy SPK-9001 shows treatment benefit in hemophilia B study Seeking AlphaFull coverage
Read more... -
A teen with Duchenne reports improvement on Solid's gene therapy, and investors take notice
May 21, 2018 | 10:30 amA teen with Duchenne reports improvement on Solid's gene therapy, and investors take notice STATFull coverage
Read more... -
Gene therapy turns people into superheroes on TV. Can it do that in real life too?
May 17, 2018 | 20:33 pmGene therapy turns people into superheroes on TV. Can it do that in real life too? MarketWatchFull coverage
Read more...